Droplet-based high-throughput cultivation for accurate screening of antibiotic resistant gut microbes

  1. William J Watterson  Is a corresponding author
  2. Melikhan Tanyeri
  3. Andrea R Watson
  4. Candace M Cham
  5. Yue Shan
  6. Eugene B Chang
  7. A Murat Eren  Is a corresponding author
  8. Savas Tay  Is a corresponding author
  1. University of Chicago, United States
  2. Duquesne University, United States

Abstract

Traditional cultivation approaches in microbiology are labor-intensive, low-throughput, and yield biased sampling of environmental microbes due to ecological and evolutionary factors. New strategies are needed for ample representation of rare taxa and slow-growers that are often outcompeted by fast-growers in cultivation experiments. Here we describe a microfluidic platform that anaerobically isolates and cultivates microbial cells in millions of picoliter droplets and automatically sorts them based on colony density to enhance slow-growing organisms. We applied our strategy to a fecal microbiota transplant (FMT) donor stool using multiple growth media, and found significant increase in taxonomic richness and larger representation of rare and clinically relevant taxa among droplet-grown cells compared to conventional plates. Furthermore, screening the FMT donor stool for antibiotic resistance revealed 21 populations that evaded detection in plate-based assessment of antibiotic resistance. Our method improves cultivation-based surveys of diverse microbiomes to gain deeper insights into microbial functioning and lifestyles.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. William J Watterson

    Pritzker School of Molecular Engineering, University of Chicago, Chicago, United States
    For correspondence
    william.j.watterson@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5065-9634
  2. Melikhan Tanyeri

    Department of Engineering, Duquesne University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  3. Andrea R Watson

    Department of Medicine, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0128-6795
  4. Candace M Cham

    Department of Medicine, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  5. Yue Shan

    Department of Medicine, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  6. Eugene B Chang

    Department of Medicine, University of Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  7. A Murat Eren

    Medicine, University of Chicago, Chicago, United States
    For correspondence
    meren@uchicago.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9013-4827
  8. Savas Tay

    Institute of Molecular Engineering, University of Chicago, Chicago, United States
    For correspondence
    tays@uchicago.edu
    Competing interests
    Savas Tay, Savas Tay is a founder and equity holder of BiomeSense Inc..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1912-6020

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (DK42086)

  • Eugene B Chang

National Institute of Diabetes and Digestive and Kidney Diseases (RC2 DK122394-01)

  • Eugene B Chang

Samuel and Emma Winters Foundation (2018-2019)

  • Melikhan Tanyeri

GI Research Foundation of Chicago

  • William J Watterson

James & Katie Mutchnik

  • A Murat Eren

National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK07074)

  • William J Watterson

Duchossois Family Institute at the University of Chicago

  • Savas Tay

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Watterson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,192
    views
  • 1,130
    downloads
  • 81
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. William J Watterson
  2. Melikhan Tanyeri
  3. Andrea R Watson
  4. Candace M Cham
  5. Yue Shan
  6. Eugene B Chang
  7. A Murat Eren
  8. Savas Tay
(2020)
Droplet-based high-throughput cultivation for accurate screening of antibiotic resistant gut microbes
eLife 9:e56998.
https://doi.org/10.7554/eLife.56998

Share this article

https://doi.org/10.7554/eLife.56998

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Teresa Attenborough, Kate A Rawlinson ... Matthew Berriman
    Research Article

    Schistosoma mansoni is a parasitic flatworm that causes the major neglected tropical disease schistosomiasis. The miracidium is the first larval stage of the life cycle. It swims and infects a freshwater snail, transforms into a mother sporocyst, where its stem cells generate daughter sporocysts that give rise to human-infective cercariae larvae. To understand the miracidium at cellular and molecular levels, we created a whole-body atlas of its ~365 cells. Single-cell RNA sequencing identified 19 transcriptionally distinct cell clusters. In situ hybridisation of tissue-specific genes revealed that 93% of the cells in the larva are somatic (57% neural, 19% muscle, 13% epidermal or tegument, 2% parenchyma, and 2% protonephridia) and 7% are stem. Whereas neurons represent the most diverse somatic cell types, trajectory analysis of the two main stem cell populations indicates that one of them is the origin of the tegument lineage and the other likely contains pluripotent cells. Furthermore, unlike the somatic cells, each of these stem populations shows sex-biased transcriptional signatures suggesting a cell-type-specific gene dosage compensation for sex chromosome-linked loci. The miracidium represents a simple developmental stage with which to gain a fundamental understanding of the molecular biology and spatial architecture of schistosome cells.

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Jessica Gray, Von Vergel L Torres ... Ian R Henderson
    Research Article

    Klebsiella pneumoniae is a global public health concern due to the rising myriad of hypervirulent and multidrug-resistant clones both alarmingly associated with high mortality. The molecular mechanisms underpinning these recalcitrant K. pneumoniae infection, and how virulence is coupled with the emergence of lineages resistant to nearly all present-day clinically important antimicrobials, are unclear. In this study, we performed a genome-wide screen in K. pneumoniae ECL8, a member of the endemic K2-ST375 pathotype most often reported in Asia, to define genes essential for growth in a nutrient-rich laboratory medium (Luria-Bertani [LB] medium), human urine, and serum. Through transposon directed insertion-site sequencing (TraDIS), a total of 427 genes were identified as essential for growth on LB agar, whereas transposon insertions in 11 and 144 genes decreased fitness for growth in either urine or serum, respectively. These studies not only provide further knowledge on the genetics of this pathogen but also provide a strong impetus for discovering new antimicrobial targets to improve current therapeutic options for K. pneumoniae infections.